| Categories: Latest

New developments in treating eczema: free webinar – registration now closed

Wednesday 9 March 2022, 6.00-7.00pm

This webinar has proven very popular and registration is now closed.

Please note we have reached full capacity for this webinar. Places for people who have already registered are allocated based on the time people join. Apologies if we reach our event capacity and you are unable to join. We will be doing more webinars in the future and are looking to record the presentations from this event for later viewing.

National Eczema Society and St John’s DermAcademy are pleased to collaborate to bring you this free webinar of informative talks from experts at the forefront of eczema research and practice. The webinar is for people living with eczema and their families, who want to learn more about the role of the immune system in eczema and hear about the new treatments being developed. Participants are encouraged to ask questions after the talks.

6.00pm Welcome and webinar overview
Professor Catherine Smith

6.05pm Our immune system and eczema – how treatments work
Professor Sara J Brown

Are you interested to learn more about your skin’s wonderful immune system? Are you puzzled about the range of different treatments that we have for eczema? This short talk aims to explain, in a simple way, the role of the immune system in eczema. We hope this will help give a clearer understanding of how treatments like moisturisers, steroids and systemic therapies may work.

6.20pm New treatments and exciting developments in eczema
Dr Andrew Pink

Research over the last decade has facilitated the development of a number of new treatments for eczema. In this talk, Dr Pink will discuss some of these, how they work, how effective they are, and how they might be used in clinical practice.

6.35pm Question and answer session with a panel including webinar speakers and Andrew Proctor, Chief Executive of National Eczema Society. Participants are encouraged to ask questions on the topics being presented, as well as other areas of eczema care.

7.00pm Close

Webinar speakers and facilitators

Professor Catherine Smith

Professor Catherine Smith
Consultant Dermatologist and Professor of Dermatology and Therapeutics at St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and Kings College London

Professor Smith is a Consultant Dermatologist and Professor of Dermatology and Therapeutics at St John’s Institute of Dermatology, Guys and St Thomas’ NHS Foundation Trust and Kings College London. She is lead clinician in national specialised services for adults with severe atopic eczema and psoriasis. Her clinical and research interests focus on inflammatory skin disease and translational medicine, extending from biomarker discovery through to interventional studies (phase II-IV), and involve major national and international collaboration. These include BIOMAP, a European-wide consortium focussed on identifying clinically relevant biomarkers in atopic eczema and psoriasis https://biomap-imi.eu/ and BEACON – a UK wide platform trial of systemic interventions in adult eczema https://www.beacontrial.org/.

Professor Sara J Brown
Professor of Dermatology and Wellcome Trust Senior Research Fellow, Centre for Genomic and Experimental Medicine, The University of Edinburgh

Professor Sara J Brown

Professor Brown is a clinical academic dermatologist – she cares for patients of all ages with a range of skin diseases, including specialist clinics for eczema. Sara’s research focusses on understanding how a person’s genetic make-up predisposes to the inflammatory skin disease atopic eczema and associated allergic/atopic conditions. The Brown Lab uses human skin cells to grow an artificial skin model which can be precisely manipulated to investigate specific molecular genetic effects. These studies are informed by genome-wide and population-based research with international collaboration. Sara and her team are currently testing gene-environment interactions, to address an important question regarding why eczema has become so much more common in recent decades. The ultimate aim of Professor Brown’s work is to define targets for the development of new and better treatments for people affected by eczema, dry skin (ichthyoses) and related allergic conditions.

Dr Andrew Pink
Consultant Dermatologist and Director of the Adult Clinical Trials Unit at St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, and Honorary Senior Clinical Lecturer, King’s College London

Dr Andrew Pink

Dr Pink is a consultant dermatologist and the Director of the Adult Clinical Trials Unit at St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospitals, London. He is an Honorary Senior Clinical Lecturer at King’s College London, ex-Honorary Secretary of the St John’s Dermatological Society, a member of the International Psoriasis Council, Chair of the Annual UK Dermatology Course for Consultants and regularly acts as a NICE clinical expert. His clinical and academic interests focus on inflammatory skin disease and translational medicine, primarily in eczema and psoriasis. Dr Pink has helped to develop a national multi-disciplinary eczema service and a very active trials unit (phase II-IV) at St. John’s. He has acted as CI on multiple trials examining novel therapies emerging in psoriasis and eczema and is the Chief Investigator for the BEACON trial, a large UK platform trial designed to assess the comparative effectiveness of systemic therapies for moderate to severe eczema in adults.